Physician profile
William Joseph Dupps
NPI 1760598296
$43,994.69
in general payments reported to CMS, 2019-2025
6 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,387 · 2020: $1,415 · 2021: $7,241 · 2022: $5,032 · 2023: $3,252 · 2024: $8,500 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $1,978 · Food and Beverage: $527 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,378.00 |
| Travel and Lodging | $1,978.28 |
| Food and Beverage | $527.02 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $17,300.00 | 2019-2024 | |
| Glaukos Corporation | $15,823.32 | 2021-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Kxl System |
| Alcon Vision LLC | $8,335.31 | 2019-2024 | Wavelight Refractive Suite |
| Carl Zeiss Meditec, INC. | $1,950.00 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $550.00 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $36.06 | 2025 | Visumax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dupps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.